NoHarm.ai and Ana Helena Ulbrich: AI applied to pharmacoepidemics and drug safety in Brazil

Understand the news at your own pace: To make the content more accessible while maintaining technical depth, this news story has been presented in two formats:

• Simplified version: Ideal for those who are not in the field but are curious about the subject.

• Technical version: Aimed at readers with prior knowledge or professional interest in the topic. Choose the reading that best suits you—or enjoy both!

In early September 2025, the American magazine Time released the first edition of its list of the 100 most influential people in the world of artificial intelligence (AI). Among names like Elon Musk and Mark Zuckerberg, Brazilian pharmacist Ana Helena Ulbrich, a resident of Capão da Canoa, Rio Grande do Sul, stands out.

Ulbrich was recognized by Time for an AI tool that she and her brother, data scientist Henrique Dias, developed to solve a real problem in the Brazilian healthcare system: reducing errors in medical prescriptions.

The project was created within the non-profit organization NoHarm.ai, which offers its system free of charge to public hospitals in Brazil and is already impacting thousands of lives.

This story shows how innovation and purpose can transform the daily lives of many people — and why it's worth keeping an eye on this Brazilian woman who makes a difference.

Accessible language: (News produced with the help of AI)

Pharmacist Ana Helena Ulbrich, selected by Time as one of the "100 Most Influential in AI 2025," co-founded the deep-tech company NoHarm.ai in partnership with her brother Henrique Dias to operate an artificial intelligence system for the automatic review of clinical prescriptions.

NoHarm.ai's algorithm currently processes approximately 5 million prescriptions per month in more than 200 hospitals, clinics, and health centers in Brazil and has already impacted more than 2.5 million patients.

From a technical standpoint, the system was developed as a clinical decision support system (CDSS), where the pharmacist continues to exercise final judgment, and AI acts as an intelligent filter for alerts on drug interactions and dosage. Ulbrich emphasizes that "it is essential that the healthcare professional make the final decision."

By maintaining the free service for hospitals in the Unified Health System (SUS) and adopting a nonprofit structure, the project exemplifies an ethical and sustainable alternative for digital health innovation—in addition to representing a relevant case study of AI-powered data curation and governance for hospital pharmacies. Technical language: (News produced with the help of AI)

Sources: Ana Helena Ulbrich: The 100 Most Influential People in AI 2025 | TIME Gaucho CEO of Tecnopuc's deep tech company is on the list of the 100 most influential people in Artificial Intelligence in the world | PUCRS

Want to share your opinion on this news? Visit our WhatsApp and Telegram channels, click on the social media links we provide, and share your thoughts in the comments!

WhatsApp: Dakila News | Global news aligned with Dakila Ecosystem research🔎 | WhatsApp Channel Telegram: https://t.me/+-dHipLWeOZQ5OG

🚨This is news for informational purposes only. 🚨